Science Explorer Back to mapMap
Discussion
Company · Évry-Courcouronnes · France

GenoSafe

genosafe.comROR OpenAlex
Research works
7
▲ 332% vs 2018-21
Citations
278
42.3 per fractional work
Top-10% rate
19.3%
all institutions 10.0%
Open access
71%
world 40%
International
58%
world 18%
GenoSafe

Not ranked overall: GenoSafe is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does GenoSafe work in?

In all years, 65% of research at GenoSafe is in Life Sciences, 26% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (50%), Medicine (26%), Environmental Science (8%). It does 1.8× the world's share of Life Sciences.

Life Sciences: 4 fractional works · 64.7% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 50.3% of its workMolecular Biology: 2 fractional works · 27.8% of its workGenetics: 1 fractional works · 22.2% of its workPhysiology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 7.6% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 2.6% of its workForestry: 0 fractional works · 2.6% of its workPlant Science: 0 fractional works · 2.6% of its workImmunology and Microbiology: 0 fractional works · 5.5% of its workImmunology: 0 fractional works · 4.6% of its workParasitology: 0 fractional works · 1.1% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.8% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workHealth Sciences: 2 fractional works · 25.5% of its workMedicine: 2 fractional works · 25.5% of its workOncology: 0 fractional works · 6.2% of its workEpidemiology: 0 fractional works · 3.8% of its workOphthalmology: 0 fractional works · 3.6% of its workPhysiology: 0 fractional works · 2.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 2.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.1% of its workInfectious Diseases: 0 fractional works · 1.7% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.2% of its workRheumatology: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 0.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workPhysical Sciences: 1 fractional works · 9.7% of its workEnvironmental Science: 1 fractional works · 8.2% of its workWater Science and Technology: 0 fractional works · 7.6% of its workEnvironmental Chemistry: 0 fractional works · 0.6% of its workComputer Science: 0 fractional works · 0.8% of its workInformation Systems: 0 fractional works · 0.8% of its workEngineering: 0 fractional works · 0.8% of its workBiomedical Engineering: 0 fractional works · 0.8% of its workALL ITS WORKGenoSafe7fractional works, all years
Life Sciences65%Physical Sciences10%Health Sciences26%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology350.3%
    2. Agricultural and Biological Sciences07.6%
    3. Immunology and Microbiology05.5%
    4. Neuroscience00.8%
    5. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Medicine225.5%
    1. Environmental Science18.2%
    2. Computer Science00.8%
    3. Engineering00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from GenoSafe?

The most cited paper from GenoSafe is "Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy" (Nathalie Cartier et al., 2009), with 1,526 citations. Next come "Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application" (185) and "Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System" (115).

Most cited papers
#PaperReleasedCitations
1 Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy Nathalie Cartier et al. · Science Open access 5 Nov 2009 1,526
2 Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application Otto-Wilhelm Merten, Sabine Charrier, Nicolas Laroudie et al. · Human Gene Therapy 2 Nov 2010 185
3 Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System Amine Meliani, Christian Leborgne, Sabrina Triffault et al. · Human Gene Therapy Methods Open access 29 Mar 2015 115
4 Strategy to detect pre-existing immunity to AAV gene therapy Lillian Falese, Krystal Sandza, Bridget Yates et al. · Gene Therapy Open access 6 Nov 2017 100
5 A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C S. Herson et al. · Brain 10 Jan 2011 90
All 28 most cited papers, with filters and sorting

Which research topics does GenoSafe publish most on?

By volume in 2022-now: Water Resource Management and Quality, Virus-based gene therapy research, CAR-T cell therapy research and Viral Infectious Diseases and Gene Expression in Insects.

Water Resource Managemen…0Water Resource Management and Quality: 0 fractional worksVirus-based gene therapy…0Virus-based gene therapy research: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksViral Infectious Disease…0Viral Infectious Diseases and Gene Expression in Insects: 0 fractional worksNeonatal and fetal brain pathology: 0 fractional worksNeonatal Respiratory Health Research: 0 fractional works
Water Science and TechnologyGeneticsOncologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Water Resource Management and Quality Water Science and Technology 0 works
  2. 2 Virus-based gene therapy research Genetics 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  5. 5 Neonatal and fetal brain pathology Pediatrics, Perinatology and Child Health 0 works
  6. 6 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 0 works
  7. 7 Retinal Development and Disorders Molecular Biology 0 works
  8. 8 COVID-19 Digital Contact Tracing Information Systems 0 works
  9. 9 CRISPR and Genetic Engineering Molecular Biology 0 works
  10. 10 Herpesvirus Infections and Treatments Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.4%not open28.6%

World: 40% of research is openly available.

with international co-authors57.7%domestic only42.3%

World: 18% is written across borders.

How has GenoSafe's research output changed?

Output in 2022-2025 was 332% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is GenoSafe as a percentage of every work published that year, 0.0000046% in 2023.

still counting0.000020%0.000040%GenoSafe0.0000024% in 202520102020

Fractional works of GenoSafe over all fractional works that year. How the balance of science has shifted.

Other research institutions in Évry-Courcouronnes

All research institutions in Évry-Courcouronnes

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about GenoSafe. Posts are plain text and can be reported.